Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
about
Characterization of gene-activated human acid- -glucosidase: Crystal structure, glycan composition, and internalization into macrophagesTechniques and tactics used in determining the structure of the trimericebolavirusglycoproteinDimeric Architecture of the Hendra Virus Attachment Glycoprotein: Evidence for a Conserved Mode of AssemblyAntibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Nondomain-Exchanged Forms but Only Binds the HIV-1 Glycan Shield if Domain ExchangedComplex-type N-glycan recognition by potent broadly neutralizing HIV antibodiesCryo-electron tomography of homophilic adhesion mediated by the neural cell adhesion molecule L1.Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1Acquisition of drug resistance and dependence by prionsA Golgi-localized mannosidase (MAN1B1) plays a non-enzymatic gatekeeper role in protein biosynthetic quality control.Structure-function analysis of STRUBBELIG, an Arabidopsis atypical receptor-like kinase involved in tissue morphogenesisEffect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion.Interaction of polysialic acid with CCL21 regulates the migratory capacity of human dendritic cells.Alpha-1,2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice.Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model.Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite.Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions.Iminosugars: Promising therapeutics for influenza infection.N-glycosylation of asparagine 8 regulates surface expression of major histocompatibility complex class I chain-related protein A (MICA) alleles dependent on threonine 24.Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16.The role of cis dimerization of signal regulatory protein alpha (SIRPalpha) in binding to CD47Calnexin-assisted biogenesis of the neuronal glycine transporter 2 (GlyT2).Shedding of glycan-modifying enzymes by signal peptide peptidase-like 3 (SPPL3) regulates cellular N-glycosylationTiming of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsinSpecificity of the high-mannose recognition site between Enterobacter cloacae pili adhesin and HT-29 cell membranesXBP1s Links the Unfolded Protein Response to the Molecular Architecture of Mature N-GlycansAcidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike.Ultrafast and high-throughput N-glycan analysis for monoclonal antibodies.Impact of Hybrid and Complex N-Glycans on Cell Surface Targeting of the Endogenous Chloride Cotransporter Slc12a2.The Arabidopsis homolog of the mammalian OS-9 protein plays a key role in the endoplasmic reticulum-associated degradation of misfolded receptor-like kinases.Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env.Glycoforms of UT-A3 urea transporter with poly-N-acetyllactosamine glycosylation have enhanced transport activity.Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin.Fucosylation and protein glycosylation create functional receptors for cholera toxin.A conserved role for the ESCRT membrane budding complex in LINE retrotranspositionUnassembled CD147 is an endogenous endoplasmic reticulum-associated degradation substrateHigh Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension.HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.The Vpu-interacting Protein SGTA Regulates Expression of a Non-glycosylated Tetherin Species.
P2860
Q27657379-7D0A40D9-27BD-4487-B1AB-576AF7C12907Q27658238-614088BA-5CD9-4580-AF43-E9B095EDBC3AQ27660451-0E26A387-34B1-4346-8A42-C6E983AB3AFCQ27664038-025B891F-6FA9-4657-9488-859266540F0BQ27674878-6A51BCBE-75EC-47B9-82F8-3FE0777E6262Q27865230-CB6B91AE-00F4-453E-973C-A11B042E35B7Q28359804-D99CC589-C1F0-4233-AC87-46ECDF5F8EBEQ28486086-F11CBE51-44D0-4C5D-8615-ABBC9E61BAE1Q30360183-733CB4F8-3A08-42D8-9D8B-3CDA23788309Q30403027-887FBCD4-273A-4461-BF1B-27DDC34192BFQ30438033-F6EBAE02-C916-411F-B442-4AA675BDB943Q33433292-283D8D57-CFA4-4B0A-82FF-F91A1F16A16AQ33502716-CDC18EA4-5736-4822-88FD-D8CC7A56D4EAQ33529115-A31185CD-B1F4-4CD6-BE22-092D7F6C8B5DQ33588593-F9CD97DD-24DC-4291-BC88-CA100D2AC2BCQ33684607-E7179CDB-5F03-4312-947D-D62AE2232D26Q33758023-BD33B701-5C08-4992-A3F2-A0849EBEEAF1Q33795341-B01E7509-70FF-43F7-83A1-F83A741E6A13Q33931165-6E613850-516F-4CF9-B292-A667994DCE5BQ34178201-CA6C19F2-4B88-4AB7-B276-642069F86918Q34351985-7B4EF533-F452-4557-AA97-440B4734247AQ34708538-06611A9D-24FD-4447-9390-071DC7D3BC05Q34807554-BEFC9761-A73D-41D7-B393-65A003ADD23DQ35076790-2A846690-8ADB-4DEF-9026-BED710BAE7F9Q35241499-3FB83A16-9836-4261-975A-1397F261C091Q35556508-8F207D72-3DFD-437F-939D-2241E755A7FCQ35819259-16AC2CC2-3230-4E30-836C-2D74B155FC9BQ35915630-2408377E-D05F-4021-BEE9-8D6DCDA90A97Q35990992-E622542A-8B9E-4EAE-9BAE-9A4CBBD9C6F7Q36006721-372B1C60-C9B5-45A0-B693-BFFEA055FEBCQ36102968-89819953-548A-4180-9CA5-59982AA10D90Q36104987-79E86A5A-6011-4981-B86C-86DACBCA6612Q36114960-BED173B2-56BE-4C60-9B1D-0D2856450936Q36363190-9415B4B1-748A-48DC-A7D8-1F35C0F9272EQ36391342-38E43F0E-99EC-4DA8-8410-B05F31BB49DBQ36393956-64AF7A15-235F-4A9B-BE7A-924DC818E06BQ36465057-D6E22D76-5A14-4147-B0C2-A7034395BBAEQ36659566-4B002657-8525-4EFC-88D0-499FE401A2B3Q36664069-BD8FD687-CB94-4A26-BB55-FD0CE5045008Q36824020-417A4FA4-36B1-4540-851A-24613F53B495
P2860
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
description
1990 nî lūn-bûn
@nan
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
@ast
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
@en
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
@nl
type
label
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
@ast
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
@en
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
@nl
prefLabel
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
@ast
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
@en
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
@nl
P2093
P1476
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
@en
P2093
P304
15599-15605
P407
P577
1990-09-01T00:00:00Z